Explain in depth the use of biomarkers for strokes and its limitations? Biomarkers for Strokes: Uses and Limitations

The Uses and Limitations of Biomarkers For Strokes

The biomarkers can be defined as molecules which are biologically specific and indicate whether a disease is progressing or not. Biomarkers have been widely used for monitoring stroke and related conditions. The use of biomarkers can give insight into the patient’s response to treatment. This information is used to help with diagnosis and improve prognosis. Since 2016, biomarkers have seen a rise in their usage. They are used for stroke monitoring and diagnosis. For instance, biomarkers such as brain-specific enolase, S-100 beta protein, neuron-specific enolase, and myelin basic protein have been used to diagnose and monitor stroke (Lampl & Sapir, 2019). To monitor the progress of the stroke, biomarkers like interleukin 6, C-reactive proteins and brain-specific enolase have been utilized. Biomarkers like glial fibrillary acidic proteins (GFAP), and ubiquitin-C-terminal hydrolase L1 (UCHL-1), can also be used to determine if stroke-related brain injury has occurred. However, there are some limitations to the use of biomarkers for stroke diagnosis and monitoring (Nelson & Jun, 2020). The first is the lack of uniformity in measuring these biomarkers. In some cases, biomarkers are not reliable enough to diagnose strokes. Cont…